Evidence map›Paper›PMID 33349875›Full record

ReviewInternational health2020

African regional progress and status of the programme to eliminate lymphatic filariasis: 2000-2020.

Kebede Deribe, Didier K Bakajika, Honorat Marie-Gustave Zoure, John O Gyapong, David H Molyneux, Maria P Rebollo

Open access · goldAbstract readReview
In one paragraph

Review in International health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
0.3field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Notes on the threadwormInternational journal for parasitology. Parasites and wildlife · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Burden, knowledge and perception of lymphatic filariasis in resource - poor communities in north central Nigeria.Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2024
    Article
  13. Article
  14. Control, elimination, and eradication efforts for neglected tropical diseases in the World Health Organization African region over the last 30 years: A scoping review.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2024
    Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Kebede DeribeExpanded Special Project for Elimination of NTDs, World Health Organization Regional Office for Africa, Cité du Djoué, P.O. Box 06 Brazzaville, Republic of Congo.
Didier K BakajikaExpanded Special Project for Elimination of NTDs, World Health Organization Regional Office for Africa, Cité du Djoué, P.O. Box 06 Brazzaville, Republic of Congo.
Honorat Marie-Gustave ZoureExpanded Special Project for Elimination of NTDs, World Health Organization Regional Office for Africa, Cité du Djoué, P.O. Box 06 Brazzaville, Republic of Congo.
John O GyapongUniversity of Health and Allied Sciences, PMB 31, Ho, Volta Region, Ghana.
David H MolyneuxLiverpool School of Tropical Medicine, Pembroke Pl, Liverpool L3 5QA, UK.
Maria P RebolloExpanded Special Project for Elimination of NTDs, World Health Organization Regional Office for Africa, Cité du Djoué, P.O. Box 06 Brazzaville, Republic of Congo.
World Health Organization Regional Office for Africa · CGBrighton and Sussex Medical School · GBLiverpool School of Tropical Medicine · GBUniversity of Health and Allied Sciences · GH

Funding

Wellcome TrustWellcome Trust 201900/Z/16/ZWorld Health Organization 001
6 · The paper itself

Abstract

To eliminate lymphatic filariasis (LF) by 2020, the World Health Organization (WHO) has launched a campaign against the disease. Since the launch in 2000, significant progress has been made to achieve this ambitious goal. In this article we review the progress and status of the LF programme in Africa through the WHO neglected tropical diseases preventive chemotherapy databank, the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) portal and other publications. In the African Region there are 35 countries endemic for LF. The Gambia was reclassified as not requiring preventive chemotherapy in 2015, while Togo and Malawi eliminated LF as a public health problem in 2017 and 2020, respectively. Cameroon discontinued mass drug administration (MDA) and transitioned to post-MDA surveillance to validate elimination. The trajectory of coverage continues to accelerate; treatment coverage increased from 0.1% in 2000 to 62.1% in 2018. Geographical coverage has also significantly increased, from 62.7% in 2015 to 78.5% in 2018. In 2019, 23 of 31 countries requiring MDA achieved 100% geographic coverage. Although much remains to be done, morbidity management and disability prevention services have steadily increased in recent years. Vector control interventions conducted by other programmes, particularly malaria vector control, have had a profound effect in stopping transmission in some endemic countries in the region. In conclusion, significant progress has been made in the LF programme in the region while we identify the key remaining challenges in achieving an Africa free of LF.

Indexed as

AnophelesElephantiasis, FilarialMalariaAnimalsCameroonGambiaHumansMalawiMosquito VectorsAfricaeliminationLFlymphatic filariasismass drug administrationneglected tropical diseasesNTDs

Identifiers

PMID33349875
PMCPMC7753167
OpenAlexW3109393585

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.